PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
November 20, 2020CirculationOpen Access

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Earlier hypertrophic cardiomyopathy guidelines required updates based on new evidence or a better understanding of earlier evidence to guide diagnosis and management in adult and pediatric patients.

Population

Adult and pediatric patients with hypertrophic cardiomyopathy

Design

Clinical practice guideline executive summary based on a comprehensive literature search

Authors

SOSteve R. OmmenSMSeema MitalMBMichael A. Burke

Discussion

Loading...

Member takes

Overview

Offers practical distillation of 2020 AHA/ACC HCM guidelines; extends prior recommendations while leaving implementation outcomes open.

Key Points

  • Provide evidence-based clinical recommendations and algorithms for the diagnosis, risk stratification, and management of hypertrophic cardiomyopathy in adult and pediatric populations.
  • Comprehensive literature search conducted across PubMed, EMBASE, Cochrane, and AHRQ databases for human studies published in English between January 1, 2010, and April 30, 2020.
  • Synthesized evidence to update previous clinical guidelines covering diagnostic evaluations, genetics, risk stratification, and therapeutic interventions.
  • Presents updated clinical algorithms for diagnostic work-up, genetic testing, and cascade family screening.
  • Outlines evidence-based guidance for medical therapy, lifestyle modifications, and invasive surgical or catheter interventions structured around individualized patient risk profiles.

Structured PICO

P
Population
Adult and pediatric patients with hypertrophic cardiomyopathy
I
Intervention
Diagnostic work-up, genetic and family screening, risk stratification approaches, lifestyle modifications, surgical and catheter interventions, and medications

Provides the 2020 AHA/ACC clinical practice guideline recommendations for the diagnosis and treatment of hypertrophic cardiomyopathy.

Cite This Study

Ommen et al. (2020) studied this question.

synapsesocial.com/papers/69bc7d1e6d7d765352a13bdahttps://doi.org/10.1161/cir.0000000000000938
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 12024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines2024 · 689 citations
  2. 2Hypertrophic cardiomyopathy management: a systematic review of the clinical practice guidelines and recommendations2024 · 9 citations
  3. 32011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy2011 · 327 citations
  4. 42011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary2011 · 86 citations
  5. 5EJHF expert consensus statement on the diagnosis and management of hypertrophic cardiomyopathy2026 · 2 citations